$53,212,199
MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Maintains embryonated egg supply infrastructure for non-seasonal pandemic vaccine production capacity.
Ensures U.S. can rapidly scale pandemic vaccine manufacturing using egg-based platforms independent of seasonal flu production constraints.
Signals sustained investment in domestic egg-based vaccine manufacturing infrastructure and supply chain resilience for pandemic response.
Reduces U.S. dependence on foreign vaccine manufacturing capacity and strengthens domestic biodefense capabilities against pandemic threats.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002123.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50125C00002_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.